Delivery Order SPE2DB22D3016-SPE2DB24FAPW0

Award Date 3/13/24
Potential Completion Date 3/14/24
Potential Value $4.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,416,097 units of Focalin XR 15 mg capsules. The $1,866.44 contract has a completion date of January 24, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has a history of supplying pharmaceuticals, medical supplies, and distribution services to DLA Troop Support Medical facilities. This delivery order is not...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $4,204.80 award is for the supply of 4,563,139,095 units of the prescription drug Focalin XR 5 mg capsules to support military treatment programs and facilities. This delivery order falls under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,838.38 contract is for the delivery of Focalin XR 5 mg capsules to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 through...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,580,158 units of Focalin XR 30 mg capsules. The potential value of this contract is $8,796.70, with a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations for this award. This contract is associated with a larger...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,653,595 units of FOCALIN XR 15 mg capsules. The contract has a potential value of $12,094.30 and a completion date of February 14, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corporation, a wholly-owned subsidiary of Amerisourcebergen Corporation. The $8,507.77 contract is for the delivery of Focalin XR 30 mg capsules to support military treatment programs and facilities. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corporation, with a potential value of $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,029,746 units of FOCALIN XR 25 MG CAPSULE 100S. The contract has a ceiling value of $4,921.00 and a period of performance through March 21, 2024. This delivery order is placed under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued at up to $999,999,999.00 through December...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Focalin XR 15 mg capsules. The contract has a potential value of $7,715.86 and a performance period through March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This order is likely part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $6,825.89 contract is for the delivery of Focalin XR 10 mg capsules by the completion date of January 31, 2024. Amerisourcebergen Drug Corp, as the prime contractor, holds an existing indefinite delivery contract (IDC) with a potential value of $999,999,999.00 from DLA through December...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $9,646.84 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The delivery order is for Focalin XR 20 mg capsules, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 and a...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAPW0
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,563,957,708 units of Focalin XR 15 mg capsules. The $4,625.78 contract has a period of performance through March 14, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. This specific order does not have any set-aside designations.

Generated 6/12/24, 10:12 AM